Watching pain teach the healthy brain to suffer too
In some stroke survivors, pain refuses to honor the boundary of injury — it crosses the body's midline, appearing on both sides as if suffering itself seeks symmetry. Researchers at Kyoto University have now traced the molecular chain of events behind this rare bilateral phenomenon, mapping how a lipid called LPA ignites immune cells that carry inflammation across the brain's great bridge, the corpus callosum, to the uninjured hemisphere. Their findings, built on the ability to actually see these molecular patterns within living tissue, offer the first clear mechanistic portrait of mirror-image pain — and with it, the first credible targets for stopping it.
- Some stroke patients face a cruel paradox: a one-sided brain injury that somehow generates pain on both sides of the body, compounding an already devastating recovery.
- The culprit appears to be a cascade — LPA surges in the damaged hemisphere, awakens microglial immune cells, and those cells ferry inflammation across the corpus callosum to the brain's healthy side.
- Using imaging mass spectrometry, Kyoto University scientists could watch this process unfold as visual molecular maps, moving the science from inference to direct observation.
- The rise of PGE2 on the uninjured side marks the moment bilateral pain takes hold — a measurable, mappable event that researchers can now pinpoint in sequence.
- Blocking LPA production or microglial activation emerges as a plausible therapeutic strategy, with potential reach beyond stroke into broader chronic neuroinflammatory conditions.
A stroke strikes in an instant, but its consequences stretch across months and years. For most survivors, pain settles on the side of the body opposite the injury — difficult enough. But in rarer cases, something more disorienting occurs: the pain spreads, crossing the body's midline, appearing on both sides at once. This mirror-image pain has long baffled clinicians and researchers alike. Now, a team at Kyoto University has mapped the molecular pathway behind it.
At the center of the story is lysophosphatidic acid — LPA — a lipid released when brain cells die. Long suspected in chronic pain, its precise role in bilateral spread was unknown. Hiroyuki Neyama and colleagues used imaging mass spectrometry to track molecules directly within tissue, watching LPA spike in the injured hemisphere and trigger the activation of microglia, the brain's resident immune cells.
What the team observed was a cascade with a clear sequence: LPA rises, microglia activate, inflammatory signals travel across the corpus callosum — the dense fiber bridge connecting the brain's two hemispheres — and PGE2, a chemical messenger of pain, climbs on the previously uninjured side. Pain follows. Corresponding author Yuki Sugiura emphasized that seeing this process as spatial molecular imagery, rather than inferring it indirectly, marked a genuine advance in understanding.
The therapeutic implications are direct: interrupting LPA production or microglial activation could prevent pain from crossing over. The team intends to explore whether the same pathway operates in other chronic pain conditions, raising the possibility that mirror-image pain after stroke is a window into something larger — a shared mechanism of neuroinflammatory suffering that, once understood, might finally be stopped.
A stroke tears through the brain in an instant, leaving damage that ripples outward for months or years. Most patients who survive know this well: the pain arrives on the opposite side of their body from where the injury occurred. But in some cases, something stranger happens. The pain doesn't stay put. It spreads, crossing the midline, appearing on both sides—a mirror image of itself, as if the body were doubling down on its own suffering. Researchers at Kyoto University have now traced the molecular machinery behind this rare and devastating phenomenon, mapping a pathway that could eventually lead to new ways to stop it.
When brain tissue dies from lack of blood flow during a stroke, the body's inflammatory response kicks in. Among the molecules that surge in response is lysophosphatidic acid, or LPA, a lipid derived from damaged cell membranes. LPA has long been suspected of playing a role in chronic pain, but exactly how it orchestrates the spread of pain from one side of the brain to both sides of the body remained a mystery. Hiroyuki Neyama and his team at Kyoto University set out to solve it, using mice that had been given strokes to study the process in real time.
The researchers employed imaging mass spectrometry, a technique that allows them to measure molecules directly within tissue sections and create visual maps of where those molecules accumulate. They watched as LPA levels spiked in the injured hemisphere. They tracked the activation of microglia—immune cells in the brain that respond to injury by becoming inflamed. They measured PGE2, a pain-related chemical messenger. What emerged was a sequence, a step-by-step cascade that explained how unilateral injury becomes bilateral pain.
First comes the initial stroke and the surge in LPA on the injured side. This triggers the activation of microglia. Those activated immune cells then send inflammatory signals across the corpus callosum, the thick bundle of nerve fibers that connects the brain's two hemispheres. As inflammation spreads to the uninjured side, PGE2 levels rise there too. And with that rise comes the pain—now present on both sides of the body, a mirror image of the original injury.
What struck the researchers most was the ability to actually see this process unfold as molecular images. Yuki Sugiura, the study's corresponding author, noted that visualizing these inflammatory pathways in such detail—watching LPA and PGE2 paint their patterns across the brain tissue—represented something genuinely new. Previous studies had inferred these connections; this team could now observe them directly, mapping the spatial relationship between molecules and the cellular responses they triggered.
The implications are significant. If LPA production and microglial activation drive the spread of post-stroke pain, then blocking either of these steps might prevent the pain from crossing over to the healthy side. The team plans to test whether the same pathway contributes to chronic pain in other conditions beyond stroke, suggesting that understanding mirror-image pain might unlock treatments for a broader category of neuroinflammatory disorders. For stroke survivors already dealing with the physical and cognitive aftermath of brain injury, the prospect of preventing or treating bilateral pain represents a concrete step toward recovery.
Citações Notáveis
Why does pain occur after a stroke, and why does it sometimes spread to both sides of the body?— Hiroyuki Neyama, Kyoto University
Our ability to visualize previously unseen inflammatory processes in the brain as molecular images of LPA and PGE2 impressed us most.— Yuki Sugiura, Kyoto University
A Conversa do Hearth Outra perspectiva sobre a história
Why does pain spread to the healthy side of the body after a stroke? That seems counterintuitive.
The brain's two hemispheres are connected by a thick cable of nerve fibers called the corpus callosum. When one side is injured, the inflammatory response doesn't stay local—it travels across that bridge to the other side, essentially teaching the healthy hemisphere to feel pain too.
And LPA is the messenger that starts this journey?
It's one of several. LPA spikes in response to the damaged tissue, but it's really the beginning of a chain reaction. It activates immune cells called microglia, which then send inflammatory signals across the corpus callosum. By the time those signals reach the other side, another pain molecule called PGE2 is elevated, and that's when the patient feels pain bilaterally.
So if you could block LPA or stop the microglia from activating, you might prevent the spread?
That's the hypothesis. The researchers haven't tested it yet, but the pathway is now clear enough that it's a logical next step. They're also wondering if the same mechanism might explain chronic pain in other conditions, not just stroke.
How rare is mirror-image pain after stroke?
It's uncommon, but when it happens, it's devastating. Patients are already dealing with the physical and cognitive effects of a stroke. Adding bilateral pain on top of that compounds the disability significantly.
What made this study different from previous work on post-stroke pain?
The imaging technique. They could actually visualize the molecules and see where they accumulated in the tissue, rather than just inferring the pathway from indirect evidence. Seeing LPA and PGE2 painted across the brain tissue as molecular images made the process tangible in a way it hadn't been before.